Simplifying Global Compliance
Rejected Counterfeiting Pact Represents a ‘Lost Opportunity’
Washington Drug Letter
Following a resounding rejection of the intellectual property (IP) pact by EU members last year, the international Anti-Counterfeiting Trade Agreement (ACTA) now appears dead as the European Commission has decided not to request a judicial review of the proposed treaty.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing